ArticleNeurosurgical review2026
Association between possible osteopenia and the growth of small unruptured intracranial aneurysms.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Both bone and intracranial arterial walls are composed of type 1 collagen, and bone mineral density (BMD) may be associated with the presence, size, and multiplicity of intracranial aneurysms. This longitudinal study aimed to investigate whether BMD was associated with aneurysm growth in patients with UIAs < 7 mm. This prospective cohort study consecutively enrolled 425 patients with UIAs < 7 mm between 2016 and 2023. Hounsfield unit (HU) values of the frontal skull on brain computed tomography (CT) were measured as a convenient surrogate for assessing skeletal status. According to the mean HU cutoff value of 719.9, patients were categorized into hypothetical normal group (> 719.9) and possible osteopenia (PO) group (≤ 719.9). The PO was defined as a CT-based surrogate, not dual-energy X-ray absorptiometry-defined osteopenia. The primary outcome was aneurysm growth. After a follow-up time of 647.0 patient-years (median duration, 15.7 months; interquartile range, 8.1-26.0 months), 46 (10.8%) aneurysms grew. The incidence rate of aneurysm growth was 7.11 per 100 person-years. Cox analysis revealed that larger initial aneurysm size, aneurysm location (anterior communicating artery, posterior communicating artery, and middle cerebral artery), uncontrolled hypertension, and PO (hazard ratio, 2.98 [95% CI, 1.55-5.71]; P = 0.001) were associated with a high risk of aneurysm growth, whereas aspirin use was associated with a decreased risk of aneurysm growth. PO was associated with an elevated risk of UIA growth. Our findings may be useful for predicting growth in UIA patients using a convenient method of measuring skull HU values on brain CT.Clinical trial registration: Not applicable.
Indexed as
Identifiers
42469542What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.